Company Study of Hualan Biological Engineering Ltd., 2011 (002007.SZ)
  • Apr/2012
  • Hard Copy
  • USD $239
  • Pages:10
  • Single User License
    (PDF Unprintable)       
  • USD $199
  • Code:
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $479
  • Hard Copy + Single User License
  • USD $289
      
Hualan Biological Engineering Ltd., (hereinafter referred to as Hualan Biological) established in 1992, is a national key high-tech enterprise engaged in the R&D and production of blood products. It became the first Chinese blood product manufacturer being granted GMP Certificate in 1998.

Presently, plasma collecting stations of Hualan Biological numbered 13 ones, 4 of which are located in Guangxi, one in Guizhou, seven in Chongqing and one in Henan, with the annual plasma collecting volume each approximating 50 tons. All the other 12 ones are under regular operation expect one plasma collecting station in Chongqing under construction.

1 Profile
2 Operation
3 Blood Products
4 Hualan Biological starts vaccine WHO pre-authentication
Operating Revenue and Net Income of Hualan Biological Engineering Ltd, 2007-2011
Operating Revenue of Hualan Biological Engineering Ltd (by Sector), 2007- 2011
Gross Margin of Hualan Biological Engineering Ltd (by Product), 2007- 2011
Operating Revenue of Hualan Biological Engineering Ltd (by Region), 2007-2011
Distribution of Plasma Collection Stations of Hualan Biological Engineering Ltd, by Aug. 2011
Release Volume of Blood Products of Hualan Biological Engineering Ltd, 2007-Jul. 2011 (Unit: 1,000 bottles)
Proportion of Blood Products Release Volume of Hualan Biological Engineering Ltd, 2008-Jul.2011
Operating Revenue of Blood Products of Hualan Biological Engineering Ltd (by Product), 2007- 2010 (Unit: RMB mln)

China Blood Products Industry Report, 2010-2011

Recent years have seen fast-growing development of blood product industry in China, with the enterprises concerned numbering 33 which can produce 10-odd blood products including human albumin, human i...

China Animal Vaccine Industry Report, 2019-2025

Chinese animal vaccine industry showed a CAGR of 8% between 2013 and 2017, but it was depressed by the outbreak of African Swine Fever in 2018 with the market size edging down 2.5% on an annualized ba...

China Blood Product Industry Report, 2020-2026

With the dynamic adjustment in the catalog of medicines covered by national medical insurance system, the scope of clinical use of almost all blood products grows tremendously, so does the reimburseme...

China Vacuum Blood Collection Device Industry Report, 2019-2025

As laboratory medicine advances, favorable polices are issued and people live a better life and care more about their health, vacuum blood collection systems get increasingly used. In 2018, global vac...

China Human Vaccine Industry Report, 2019-2025

China has been the world’s biggest producer and consumer of human vaccines over four decades of planned vaccination, a program that has reduced incidence of multiple vaccine-targeted infectious diseas...

China Independent Clinical Laboratory Industry Report, 2019-2025

China's independent clinical laboratory industry is still in its infancy. In 2018, it only saw the penetration rate of about 5%, far below 40% or more in Europe, the United States and Japan. The main ...

Global and China Monoclonal Antibody Industry Report, 2019-2025

Global monoclonal antibody market can be presented as follows: 1. Monoclonal antibody drug market booms and is highly concentrated with the approvals for such drugs.Monoclonal antibody drugs have bee...

China Contract Research Organization (CRO) Industry Report, 2019-2025

The steadily growing global pharmaceutical industry where more and more new drugs have been approved, and the soaring spending on drug research and development in recent years, are a boon for global c...

China Blood Product Industry Report, 2019-2025

With the adjustment of the national medical insurance catalogue, the clinical application and reimbursement rate of almost all blood products have been greatly improved, and the market for blood produ...

China Human Vaccine Industry Report, 2018-2022

As the world’s largest producer of human vaccines, China has established a full-life-cycleregulatory system covering vaccine R&D, production, distribution, and vaccination. The lot release volum...

China Contract Research Organization(CRO) Industry Report, 2017-2021

Under the pressure from higher R&D costs, longer R&D cycle and lower R&D success rate in pharmaceutical industry worldwide, over 50 percent of pharmaceutical enterprises have had the devel...

China Vacuum Blood Collection Device Industry Report, 2017-2021

China’s vacuum blood collection device industry now flourishes after start-up and growth stages. Along with steady improvement in economic environment, rising per-capita disposable income, greater awa...

China Independent Clinical Laboratory Industry Report, 2017-2021

China's independent clinical laboratory industry started late, and is still in its infancy. In 2016, it only saw the penetration rate of about 4%, far below 40% or more in Europe, the United States an...

China Human Vaccine Industry Report, 2017-2021

The human vaccine industry presented the following main characteristics in 2016 in China: 1. Lot release volume of human vaccines declined.Affected by the illegal vaccine case in Mar 2016 in Shandong...

China Independent Clinical Laboratory Industry Report, 2016-2020

Owing to a large population base, uneven distribution of medical resources among regions, aging population, and continuous advance of health care reform, the Chinese independent clinical laboratory ma...

China Human Vaccine Industry Report, 2016-2020

Amid the unsafe domestic vaccine events, China’s human vaccine lot release volume in 2015 fell by 17.9% year on year to only 650 million doses,touching a 5-year low. Moreover, with the improvements in...

China Animal Vaccine Industry Report, 2016-2020

Animal vaccine is a kind of biological agent that enables inoculated animals to produce active immunity for disease prevention. In recent years, European and American animal vaccine markets have seen ...

China Blood Product Industry Report, 2016-2019

Recombinant blood products have developed for many years in foreign countries, but China’s blood products are still proteins extracted from human blood. Thus, reserves and control of plasma resources ...

China Contract Research Organization (CRO) Industry Report, 2015-2018

In recent years, China's contract research organization (CRO) industry has developed rapidly, with the market size rising from RMB8.5 billion in 2007 to RMB42.6 billion in 2014, registering a CAGR of ...

2005- www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号